Gene · 8321
NIH grants1,683
NIH grants whose papers are about the gene, through NIH's grant-paper links.
521 to 540 of 1,683
Download this page as JSON| Grant | Title | FZD1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI132387 | Molecular basis of action and pathogenesis of Clostridium difficile toxin B | 1 | 2021 |
| R01AR042742 | Linkage Analysis of Familial Psoriasis | 1 | 2021 |
| R01AR049069 | Molecular Control of Bone Formation | 1 | 2021 |
| R01AR069055 | Decoding Methylation Mediated Epigenomic Contributions to Male Osteoporosis | 1 | 2021 |
| R01AR070748 | Regulation of Skeletal Growth by Soft Tissue Extracellular Matrix | 1 | 2021 |
| R01AR070773 | Direct and indirect contributions of perivascular stem cells to bone healing | 1 | 2021 |
| R01AR070864 | Evaluating the Potential of Human Induced Pluripotent Stem Cells (hiPSC) For Cartilage Repair | 1 | 2021 |
| R01CA085533 | Regulation of p53 acetylation and deacetylation in tumorigenesis. | 1 | 2021 |
| R01CA155620 | RON Receptor in Pancreatic Cancer Biology and Therapy | 1 | 2021 |
| R01CA210637 | Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia | 1 | 2021 |
| R01CA211336 | Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple Myeloma | 1 | 2021 |
| R01CA214019 | Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy | 1 | 2021 |
| R01CA214531 | Frizzled 9 loss and regulation in preventing the progression of pre-malignant lung lesions | 1 | 2021 |
| R01CA214965 | The role and mechanism of FTO in leukemogenesis and drug response | 1 | 2021 |
| R01CA215284 | Determining the Role of DNA Methylation Deregulation in Oncogenesis | 1 | 2021 |
| R01CA218600 | Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias | 1 | 2021 |
| R01DE019412 | PGC-1a regulates inflammation and bone loss in periodontitis through NF-kB | 1 | 2021 |
| R01DE026767 | Molecular Regulatory Mechanism of Calvaria Bone Development and Homeostasis | 1 | 2021 |
| R01DK054254 | CEACAM and Insulin Action | 1 | 2021 |
| R01DK096239 | Understanding human pancreas development for diabetes cell-replacement therapy | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/grants?page=27